131
TITLE: Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers
AUTHORS: Fernandes, AR; Santos, AC; Sanchez Lopez, E; Kovacevic, AB; Espina, M; Calpena, AC; Veiga, FJ; Garcia, ML; Souto, EB ;
PUBLISHED: 2018, SOURCE: SKIN PHARMACOLOGY AND PHYSIOLOGY, VOLUME: 31, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
132
TITLE: Molecular dynamics simulations reveal the influence of dextran sulfate in nanoparticle formation with calcium alginate to encapsulate insulin
AUTHORS: Nadvorny, D; Soares Sobrinho, JL; Soares, MFD; Ribeiro, AJ; Veiga, F; Seabra, GM;
PUBLISHED: 2018, SOURCE: JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, VOLUME: 36, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
133
TITLE: Poly(lactic-co-glycolic acid) (PLGA) matrix implants
AUTHORS: Sequeira, JAD; Santos, AC; Serra, J; Veiga, F; Ribeiro, AJ;
PUBLISHED: 2018, SOURCE: Nanostructures for the Engineering of Cells, Tissues and Organs: From Design to Applications
INDEXED IN: Scopus CrossRef: 19
IN MY: ORCID
134
TITLE: miR-145-loaded micelleplexes as a novel therapeutic strategy to inhibit proliferation and migration of osteosarcoma cells  Full Text
AUTHORS: Mariana Magalhaes; Mauro Almeida; Elisiario Tavares da Silva; Fernanda M F Roleira; Carla Varela; Joana Jorge; Ana Cristina Gonçalves ; Rui Albuquerque Carvalho; Francisco Veiga; Ana Claudia Santos; Ana Figueiras;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 123
INDEXED IN: Scopus WOS CrossRef: 17
IN MY: ORCID
135
TITLE: Bioequivalence of topical generic products. Part 2. Paving the way to a tailored regulatory system  Full Text
AUTHORS: Miranda, M; Sousa, JJ; Veiga, F; Cardoso, C; Vitorino, C;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 122
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
136
TITLE: A practical framework for implementing Quality by Design to the development of topical drug products: Nanosystem-based dosage forms  Full Text
AUTHORS: Simões, A; Veiga, F; Figueiras, A; Vitorino, C;
PUBLISHED: 2018, SOURCE: International Journal of Pharmaceutics, VOLUME: 548, ISSUE: 1
INDEXED IN: Scopus CrossRef: 34
IN MY: ORCID
137
TITLE: A Tutorial for Developing a Topical Cream Formulation Based on the Quality by Design Approach  Full Text
AUTHORS: Simões, A; Veiga, F; Vitorino, C; Figueiras, A;
PUBLISHED: 2018, SOURCE: Journal of Pharmaceutical Sciences, VOLUME: 107, ISSUE: 10
INDEXED IN: Scopus CrossRef: 41
IN MY: ORCID
138
TITLE: Bioequivalence of topical generic products. Part 1: Where are we now?  Full Text
AUTHORS: Miranda, M; Sousa, JJ; Veiga, F; Cardoso, C; Vitorino, C;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 123
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
139
TITLE: Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold  Full Text
AUTHORS: Santos, AC; Ferreira, C; Veiga, F; Ribeiro, AJ; Panchal, A; Lvov, Y; Agarwal, A;
PUBLISHED: 2018, SOURCE: ADVANCES IN COLLOID AND INTERFACE SCIENCE, VOLUME: 257
INDEXED IN: Scopus WOS CrossRef: 158
IN MY: ORCID
140
TITLE: Subcutaneous delivery of monoclonal antibodies: How do we get there?  Full Text
AUTHORS: Viola, M; Sequeira, J; Seica, R; Veiga, F; Serra, J; Santos, AC; Ribeiro, AJ;
PUBLISHED: 2018, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 286
INDEXED IN: Scopus WOS CrossRef: 149
IN MY: ORCID
Page 14 of 38. Total results: 371.